Leila E. G. M.
- Country
- France
- Department
- Hémato-Oncologie Pédiatrique
Research Overview
Data & Insights
Has run more than one trial at 0 of 105 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating anaplastic large cell lymphoma (ALCL) in children and adolescents, with particular expertise in ALK-positive variants of this condition.
- Lymphoma Management
- Pediatric Cancer Care
- ALK-Positive Disease Treatment
Research interests center on developing therapeutic approaches for standard-risk ALCL patients.
Targeted Therapies
Focus on implementing targeted therapeutic strategies using specific treatments like Vinblastine for pediatric lymphoma patients.
- Monotherapy Approaches
- Long-term Treatment Protocols
- Risk-Adapted Therapy
Expertise in developing extended duration treatment protocols for optimal patient outcomes.
Clinical Innovation
Advancing treatment methodologies for standard risk lymphoma cases with emphasis on achieving high cure rates through targeted interventions.
- Treatment Optimization
- Therapeutic Efficacy
- Patient Stratification
Dedicated to improving survival rates through innovative treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.